From Bacteria to Bedside: The Arrival of CRISPR Medicine
Today’s landmark approval by the US Food and Drug Administration of Vertex Pharmaceuticals’ and CRISPR Therapeutics’ EXA-cell, the world’s first CRISPR-based treatment, marks a groundbreaking shift in how we tackle intractable diseases.
Raghu Raghurama16z.com
The Little Tech Agendaa16z.com
Engaging the Unengaged at Home with Max Cohen and Cameron Behara16z.com
Evolve or Die: The Future of the Creative Process, Artist Authenticity, and the Value of the Musica16z.com
The State of AI & Educationa16z.com
America's Energy Problem: The Grid That Built America Can’t Power Its Futurea16z.com
The Future of Coding: AI Code Generation ExplainedCohere
iOS 14.5 goes live with Watch unlocking, tracking transparency and kissing emojisTechcrunch
Netflix's ad-supported tier won’t have all content at launchTechcrunch
AssemblyAI Medical Mode for Emergency MedicineAssemblyai
Berlin's Mayd grabs $34M for fast pharmacy deliveryTechcrunch
China sides with Emmanulle Charpentier and Jennifer Doudna in CRISPR patent warTechcrunch
Medicine Inventory Management SystemRetool
Must-Know AI Use Cases in MedicineDeepgram
Distributed E. Coli Biocomputer Solves Maze ProblemsThenewstack
Gravity: Analog EMG Sensor by OYMotiondfrobot.com
Worry-Free Purchaseanker.com
Roboticists at CES 2026: A Sample Itineraryces.tech
Digital Health Advocates at CES 2026: A Sample Itineraryces.tech
Tech and Medicine Must Evolve Togetherces.tech
